BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

AGC Biologics to Open New Manufacturing Site in Yokohama, Japan

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced plans to construct...

January 05, 2024 | News

WuXi XDC Partners with IntoCell to Boost ADC Discovery and Development

Under the agreement, IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate (OHPASTM) Linker and novel...

January 03, 2024 | News

AGC announces strategic expansion of its Biopharmaceutical CDMO capability in Yokohama, Japan, signaling a new era of innovation and growth

This expansion has been selected by the Japanese Ministry of Economy, Trade and Industry (METI) as part of its "Developing biopharmaceutical manufacturin...

December 26, 2023 | News

Genevoyager (Wuhan) Launches State-of-the-Art CDMO Facility to Propel Gene Therapy Advancements

The newly inaugurated cGMP facility is equipped with its proprietary One-Bac 4.0 System with Sf-RVF® cell line and adheres to the NMPA, FDA and EM...

December 21, 2023 | News

Australian Neuren Phase 2 Trial Reveals Significant Improvements in Phelan-McDermid Syndrome

Highlights: Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures Improvements were con...

December 19, 2023 | News

Atmo Biosciences achieves patient recruitment target for dysmotility pivotal clinical study

Atmo Biosciences, a company commercializing the world’s first ingestible gas-sensing capsule that provides insights into gut health and microbiome fu...

December 14, 2023 | News

WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader

The three-day comprehensive audit covered the CDMO site's drug substance (DS) facility, drug product (DP) facility, QC laboratories, warehouse, and utiliti...

December 07, 2023 | News

Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million...

November 30, 2023 | News

WuXi Biologics Achieves Breakthrough Productivity of ~6 g/L/day in Integrated Continuous Process at Pilot Scale

By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture...

November 23, 2023 | News

WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange

WuXi XDC issued a total of 178,446,000 shares under the global offering at an offer price of HK$20.60 per share (being the high-end of the indica...

November 20, 2023 | News

Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma

The company can initiate a project on four continents and easily transfer validated methods across labs, allowing therapeutic trials to extend to virtually...

November 03, 2023 | News

Samsung Biologics and Kurma Partners Forge Biologics Development & Manufacturing Alliance for Kurma's Portfolio

- Samsung Biologics to provide de-risking, development, manufacturing services, and seamless transitions for biologics from early stages of developmen...

October 25, 2023 | News

XINGIMAGING and MITRO BIOTECH Merge for Global CRO Operations

As a combined company, Mitro will expand its capabilities to provide full CRO services, including clinical and clinical imaging management, in China&n...

October 24, 2023 | News

Aragen Commissions state-of-the-art Formulations Manufacturing Facility in India

This state-of-the-art facility, set up at an investment of USD 3Mn, is located at the Mallapur Campus in Hyderabad and spans over 12,000 square feet area. ...

October 20, 2023 | News

Stay Connected